-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cerevel Therapeutics Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
- Cerevel Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$132M, a 26.5% decline year-over-year.
- Cerevel Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$460M, a 18.8% decline year-over-year.
- Cerevel Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$433M, a 23.1% decline from 2022.
- Cerevel Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$352M, a 56% decline from 2021.
- Cerevel Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$225M, a 48.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)